ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Return on equity 2019–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.2%FY2025 · since FY2019: -12.0% → -27.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -27.2% | +51.5 pp |
| FY2024 | -78.7% | -5.6 pp |
| FY2023 | -73.0% | -29.9 pp |
| FY2022 | -43.1% | -8.8 pp |
| FY2021 | -34.3% | -14.6 pp |
| FY2020 | -19.7% | -7.7 pp |
| FY2019 | -12.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice